118 related articles for article (PubMed ID: 3545855)
1. Characterisation of two probes for the localisation of enkephalinase in rat brain: [3H]thiorphan and a 125I-labeled monoclonal antibody.
Pollard H; De la Baume S; Bouthenet ML; Schwartz JC; Ronco P; Verroust P
Eur J Pharmacol; 1987 Jan; 133(2):155-64. PubMed ID: 3545855
[TBL] [Abstract][Full Text] [Related]
2. Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand.
De la Baume S; Schwartz JC
Eur J Pharmacol; 1988 Apr; 149(1-2):121-9. PubMed ID: 3165067
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
[TBL] [Abstract][Full Text] [Related]
4. Binding of the bidentate inhibitor [3H]HACBO-Gly to the rat brain neutral endopeptidase "enkephalinase".
Waksman G; Bouboutou R; Devin J; Besselievre R; Fournie-Zaluski MC; Roques BP
Biochem Biophys Res Commun; 1985 Aug; 131(1):262-8. PubMed ID: 3899113
[TBL] [Abstract][Full Text] [Related]
5. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
6. Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody.
Ronco P; Pollard H; Galceran M; Delauche M; Schwartz JC; Verroust P
Lab Invest; 1988 Feb; 58(2):210-7. PubMed ID: 3276960
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.
Chipkin RE; Kreutner W; Billard W
Eur J Pharmacol; 1984 Jun; 102(1):151-4. PubMed ID: 6383841
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain.
Waksman G; Hamel E; Fournié-Zaluski MC; Roques BP
Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1523-7. PubMed ID: 3006054
[TBL] [Abstract][Full Text] [Related]
9. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
10. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
[TBL] [Abstract][Full Text] [Related]
11. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological "enkephalinase" inhibition in man.
Marcello F; Grazia SM; Sergio M; Federigo S
Adv Exp Med Biol; 1986; 198 Pt B():153-60. PubMed ID: 3028074
[TBL] [Abstract][Full Text] [Related]
13. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
15. Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.
Coquerel A; Dubuc I; Menard JF; Kitabgi P; Costentin J
Brain Res; 1986 Nov; 398(2):386-9. PubMed ID: 3542125
[TBL] [Abstract][Full Text] [Related]
16. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells.
Lentzen H; Palenker J
FEBS Lett; 1983 Mar; 153(1):93-7. PubMed ID: 6337881
[TBL] [Abstract][Full Text] [Related]
17. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
[TBL] [Abstract][Full Text] [Related]
18. Rat brain enkephalinase: characterization of the active site using mercaptopropanoyl amino acid inhibitors, and comparison with angiotensin-converting enzyme.
Gordon EM; Cushman DW; Tung R; Cheung HS; Wang FL; Delaney NG
Life Sci; 1983; 33 Suppl 1():113-6. PubMed ID: 6319849
[TBL] [Abstract][Full Text] [Related]
19. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
Haffmans J; Dzoljic MR
Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
